For example, the RAS oncogene has been shown to be able to induce VEGF expression in human cancer cells where HIF-1α is unable to bind to the VEGF promoter due to mutations in the HIF-1α binding sites of the promoter [34,56]. Here, HIF1A is linked to cancer.